# Michigan Reproductive and IVF Center, PLLC – FDA 483, Jun 3, 2026

Source: https://www.keypedia.com/records/483/michigan-reproductive-and-ivf-center-pllc/32412764-4232-40be-b9c1-50994545ef27

> FDA 483 for Michigan Reproductive and IVF Center, PLLC on June 03, 2026. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Michigan Reproductive and IVF Center, PLLC
- Inspection Date: 2026-06-03
- Product Type: other
- Office Name: Detroit District Office
- Summary: Michigan Reproductive and IVF Center, PLLC in Grand Rapids, MI, was cited for multiple deficiencies related to human cells, tissues, and cellular and tissue-based products (HCT/P) donor eligibility. The inspection revealed significant issues with donor screening procedures, incomplete medical record reviews for communicable diseases, and inaccurate or undocumented eligibility determinations. These findings indicate a serious lack of control over the safety and suitability of donated reproductive tissues.

## Related Documents

- [483 - 2023-04-27](https://www.keypedia.com/records/483/michigan-reproductive-and-ivf-center-pllc/62fd22e5-f19f-4500-981c-fd27ac336e2d) — date: April 27, 2023

## Related Officers

- [Investigator](https://www.keypedia.com/people/irina-gaberman/c863b2de-4c64-40d2-a390-289d293e5a8f)

Company: https://www.keypedia.com/companies/michigan-reproductive-and-ivf-center-pllc/88117601-3247-4324-9232-c339db8e9365

Office: https://www.keypedia.com/offices/detroit-district-office/b09a1815-a000-40c0-bb44-5432ce87ed03